Why is Beta Drugs Ltd falling/rising?

As of 21-Jul, Beta Drugs Ltd is experiencing a decline in its stock price, currently at 1,677.65, reflecting a decrease of 4.35 points or 0.26%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a rise in delivery volume by 5.73% on July 18, which suggests increased investor participation, the stock's performance over the past week and month shows a decline of 3.58% and 5.43%, respectively. Year-to-date, the stock has fallen by 12.10%, contrasting sharply with its impressive one-year return of 35.78% and three-year return of 125.19%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Beta Drugs Ltd's short-term performance is underwhelming compared to the Sensex, which has remained relatively flat with a 0.03% increase over the past week. While the benchmark has shown a slight decline of 0.09% over the past month, Beta Drugs Ltd's performance has been significantly worse, indicating that the stock is not keeping pace with the overall market. This underperformance, combined with the stock's current trading position below key moving averages, suggests a challenging environment for Beta Drugs Ltd amidst a generally stable market backdrop.